What Does a CMV IgG Avidity Test Mean in Pregnancy?
At a Glance
A CMV IgG avidity test estimates how recently a pregnant person was infected: low avidity usually suggests a recent infection, while high avidity usually suggests an older one. Results are not perfect and cannot show whether the baby is infected or predict severity.
An IgG avidity test measures how tightly your immune system’s antibodies bind to the cytomegalovirus (CMV). For pregnant women who test positive for CMV antibodies, this test helps doctors estimate roughly when the infection occurred [1]. The timing of the infection is critical because it significantly affects the potential risk to your developing baby.
When your body first fights off a CMV infection, it produces antibodies that bind loosely to the virus. Over the following months, these antibodies mature and learn to bind much more tightly [1]. The “avidity” refers to this binding strength. By measuring it, your doctor can look for clues about whether your infection is new (a primary infection) or if it happened in the past [2].
Why Your Doctor Ordered This Test
If a routine blood test shows that you have CMV antibodies, it generally means you have been exposed to the virus [2].
- IgG antibodies show that you have had CMV at some point in your life.
- IgM antibodies are usually the first to appear after a new infection.
However, an IgM test alone cannot reliably tell when the infection happened. IgM antibodies can remain in your blood for many months after an old infection, or they can sometimes appear due to a different virus entirely [3].
Because the risk of the virus causing severe developmental problems for your baby is highest if you catch CMV for the first time just before or during pregnancy, your doctor ordered the IgG avidity test to help clarify the timeline [4][5].
What Your Results Mean
Avidity is usually reported as low, high, or intermediate. The exact timelines depend on the specific laboratory and the test they use. It is important to know that avidity is not a perfect clock, but it provides a helpful estimate:
- Low Avidity: This means the antibodies are binding loosely, suggesting a recent infection. Depending on the lab’s test, this usually points to an infection within the past 3 to 4 months [6][3]. If you are early in your pregnancy, a low avidity result suggests you may have caught the virus right around conception or during pregnancy. This carries a higher risk of passing the virus to your baby [4].
- High Avidity: This means your antibodies bind tightly, suggesting the infection occurred further in the past [7]. If you are tested early in your first trimester and have high avidity, it generally means you were infected before you became pregnant, which significantly lowers the risk of severe complications for your baby [5][4]. However, a high avidity test later in pregnancy could mean you were infected earlier in the same pregnancy.
- Intermediate (Moderate) Avidity: This result is in a gray area and does not provide a clear timeline [8]. Your doctor will need to look at your full medical history, and may repeat the test later or use other methods to understand your situation [5].
Understanding the Risks to Your Baby
The timing of your CMV infection plays a major role in your baby’s health:
- Transmission risk vs. severity: The chance of passing the virus to your baby actually increases as your pregnancy progresses. In one specific study, transmission rates were roughly 10% for infections around conception, 41% during the first trimester, and 52% during the second trimester [4][9]. However, if the virus does cross the placenta early in pregnancy, the consequences for the baby (such as hearing loss or developmental issues) tend to be much more severe [4][10]. Late-pregnancy infections are more common but usually cause fewer serious problems.
Important context:
- Avidity only tests the mother: It does not tell you if the virus has actually crossed the placenta or if the baby is infected [11].
- High avidity does not mean zero risk: While a past infection (high avidity) lowers the risk significantly, the virus can sometimes reactivate, or you could be reinfected with a different strain [12][13].
- Symptoms are unreliable: Many primary CMV infections cause no symptoms at all. You cannot rely on having had (or not having had) a fever or swollen glands to date your infection.
Next Steps After Your Results
If your avidity test and overall bloodwork suggest a recent primary infection, your care team will likely recommend closer monitoring and discuss your options:
- Specialist Referrals: You may be referred to a maternal-fetal medicine specialist who has expertise in managing complex pregnancies [14].
- Targeted Ultrasounds: Your doctor will likely recommend detailed, regular ultrasounds to check the baby’s growth and look for signs of infection. In some cases, if ultrasounds show concerning signs, a specialized fetal MRI might be considered [15][16]. Keep in mind that a normal ultrasound is reassuring but cannot entirely rule out an infection or future complications like hearing loss [10][17].
- Amniocentesis: This is an invasive procedure that takes a small sample of amniotic fluid to test directly for the virus. It is the most accurate way to find out if the baby has been infected, but it carries a small risk of complications, such as miscarriage. Guidelines often recommend doing this after 21 weeks of pregnancy and at least 6 to 8 weeks after your estimated time of infection [3][10]. Importantly, while amniocentesis can confirm if the baby is infected, it cannot predict how severely the baby will be affected.
Common questions in this guide
Why might I need a CMV IgG avidity test during pregnancy?
What does low CMV IgG avidity mean?
What does high CMV IgG avidity mean in early pregnancy?
Can a CMV avidity test tell whether my baby is infected?
What does intermediate CMV avidity mean?
What follow-up tests may be discussed after a recent CMV infection?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Cytomegalovirus Infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What were my exact avidity results, and what timeframe do they point to for my infection based on the specific lab test used?
- 2.Based on my complete bloodwork and how far along I am, what is the estimated risk of the virus being transmitted to my baby?
- 3.Do you recommend an amniocentesis to check if the baby has been infected, and if so, what are the exact risks of the procedure for my pregnancy?
- 4.What would a positive or negative amniocentesis result actually change about our monitoring or treatment plan?
- 5.Should I be referred to a maternal-fetal medicine specialist for further evaluation and targeted ultrasounds?
References
References (17)
- 1
The significance of antigen-antibody-binding avidity in clinical diagnosis.
Li Y, Yang HS, Klasse PJ, Zhao Z
Critical reviews in clinical laboratory sciences 2025; (62(1)):9-23 doi:10.1080/10408363.2024.2379286.
PMID: 39041650 - 2
Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy.
Fourgeaud J, Nguyen CÂ, Guilleminot T, et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2023; (169()):105614 doi:10.1016/j.jcv.2023.105614.
PMID: 37982548 - 3
Diagnosis and antenatal management of congenital cytomegalovirus infection.
, Hughes BL, Gyamfi-Bannerman C
American journal of obstetrics and gynecology 2016; (214(6)):B5-B11.
PMID: 26902990 - 4
Evaluation and Management of Congenital Cytomegalovirus Infection.
Coskun E, Kakkar F, Riley LE, et al.
Obstetrics and gynecology 2025; (145(3)):297-306 doi:10.1097/AOG.0000000000005840.
PMID: 39847776 - 5
Comparative performance of CMV IgM and IgG avidity assays for diagnosing a recent primary infection in the first trimester of pregnancy.
Veyrenche N, Fourgeaud J, Mekouar M, et al.
Journal of clinical microbiology 2026; (64(9)):e0054526 doi:10.1128/jcm.00545-26.
PMID: 42573416 - 6
Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K, Koshizuka T, Kanno R, et al.
Microbiology and immunology 2019; (63(5)):172-178 doi:10.1111/1348-0421.12683.
PMID: 31012489 - 7
Evaluation of the new LIAISON(®) CMV IgG, IgM and IgG Avidity II assays.
Delforge ML, Desomberg L, Montesinos I
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015; (72()):42-5.
PMID: 26395519 - 8
Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.
Delforge ML, Eykmans J, Steensels D, et al.
Diagnostic microbiology and infectious disease 2019; (93(3)):208-212 doi:10.1016/j.diagmicrobio.2018.09.013.
PMID: 30361044 - 9
New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
Egloff C, Sibiude J, Vauloup-Fellous C, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (61(1)):59-66 doi:10.1002/uog.26039.
PMID: 35900718 - 10
Cytomegalovirus infection in pregnancy - An update.
Navti OB, Al-Belushi M, Konje JC,
European journal of obstetrics, gynecology, and reproductive biology 2021; (258()):216-222 doi:10.1016/j.ejogrb.2020.12.006.
PMID: 33454510 - 11
Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection.
Tanimura K, Tairaku S, Morioka I, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (65(10)):1652-1658 doi:10.1093/cid/cix621.
PMID: 29020153 - 12
Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review.
Iijima S
Journal of clinical medicine 2022; (11(17)) doi:10.3390/jcm11175006.
PMID: 36078936 - 13
Maternal Cytomegalovirus (CMV) Serology: The Diagnostic Limitations of CMV IgM and IgG Avidity in Detecting Congenital CMV Infection.
Chan ES, Suchet I, Somerset D, et al.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2024; (27(6)):530-544 doi:10.1177/10935266241253477.
PMID: 39270128 - 14
Diagnosis and management of congenital Cytomegalovirus: Critical Appraisal of Clinical Practice Guidelines.
Sorrenti S, Elbarbary N, D'Antonio F, et al.
European journal of obstetrics, gynecology, and reproductive biology 2025; (306()):172-180 doi:10.1016/j.ejogrb.2025.01.020.
PMID: 39848071 - 15
First-line noninvasive management of cytomegalovirus primary infection in pregnancy.
Denef M, Noel L, Bruck G, et al.
Journal of perinatal medicine 2022; (50(3)):270-276 doi:10.1515/jpm-2021-0384.
PMID: 34923781 - 16
Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study.
Di Mascio D, Rizzo G, Khalil A, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (61(1)):67-73 doi:10.1002/uog.26054.
PMID: 36056700 - 17
Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.
Naing ZW, Scott GM, Shand A, et al.
The Australian & New Zealand journal of obstetrics & gynaecology 2016; (56(1)):9-18 doi:10.1111/ajo.12408.
PMID: 26391432
This page is for informational purposes only and does not constitute medical advice. Your obstetric or maternal-fetal medicine team should interpret your CMV results and discuss testing options for your pregnancy.